Vita 34 AG V3V
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €4.66
- Day Range
- €4.82–4.82
- 52-Week Range
- €3.69–7.32
- Bid/Ask
- €4.82 / €5.14
- Market Cap
- €84.02 Mil
- Volume/Avg
- 1,183 / 2,444
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.01
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group’s reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 815
- Website
- https://www.vita34.de
Comparables
Valuation
Metric
|
V3V
|
BFV
|
7096
|
---|---|---|---|
Price/Earnings (Normalized) | — | 124.85 | 49.20 |
Price/Book Value | 6.05 | 6.29 | 7.51 |
Price/Sales | 1.01 | 5.08 | 8.12 |
Price/Cash Flow | — | — | 56.10 |
Price/Earnings
V3V
BFV
7096
Financial Strength
Metric
|
V3V
|
BFV
|
7096
|
---|---|---|---|
Quick Ratio | 0.61 | 4.15 | 1.17 |
Current Ratio | 0.68 | 4.15 | 1.20 |
Interest Coverage | −5.37 | — | — |
Quick Ratio
V3V
BFV
7096
Profitability
Metric
|
V3V
|
BFV
|
7096
|
---|---|---|---|
Return on Assets (Normalized) | −6.63% | 6.57% | 6.65% |
Return on Equity (Normalized) | −56.38% | 18.65% | 16.43% |
Return on Invested Capital (Normalized) | −14.87% | 13.00% | 16.34% |
Return on Assets
V3V
BFV
7096
Medical Care Facilities Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Xfptkhkk | Qwztkv | $87.7 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Nyysgx | $15.2 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Mrjxdzw | $15.2 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Ywpz | $12.5 Bil | |
UHS
| Universal Health Services Inc Class B | — | Bphxvy | $12.2 Bil | |
DVA
| DaVita Inc | Xfsldfsph | Tmgsb | $11.9 Bil | |
FMCQF
| Fresenius Medical Care AG | — | Mnydqs | $11.3 Bil | |
FMS
| Fresenius Medical Care AG ADR | Nsxx | Fshstg | $11.3 Bil | |
THC
| Tenet Healthcare Corp | Pnppvgs | Nfpd | $10.5 Bil | |
AMN
| AMN Healthcare Services Inc | Fgjyptx | Ttnqnj | $2.3 Bil |